Substance Abuse Pre-Treatment Screening Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorThe University of Texas Health Science Center, Houston
About this trial
The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Willing and able to participate in 3- to 6-month treatment program.
At least 18 years of age.
Seeking treatment for substances of abuse including (cocaine, opiates, and alcohol).
Generally physically healthy.
Disqualifiers
Pregnant or breastfeeding.
Mandated by the courts/parole officers to attend treatment.
Not seeking treatment for substances of abuse.
Plans to move from the Houston area within the 3- to 6-month treatment period.
Trial population
Cocaine Dependent Subjects
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
modafinil
Drug400 mg daily
d-amphetamine
Drug60mg daily
L-Dopa
Drug800/200mg daily
Naltrexone
Drug50mg daily
Treatment groups
7,500 Participants
are divided into 1 treatment groupGroup A: A4 interventions
Trial outcomes
Primary outcomes
1
Urine Toxicology
Time frame
6 weeks to 24 weeksSecondary outcomes
1
Demographics
Time frame
6 weeks to 24 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Texas Health Science Center, Houston
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov